Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**ZFP91 zinc finger protein pseudogene 1** (ZFP91P1) is a transcribed pseudogene, expressed as a long non-coding RNA (lncRNA). Unlike its parent gene ZFP91, which encodes an E3 ubiquitin ligase involved in non-canonical NF-κB signaling, ZFP91P1 does not encode a functional protein. Instead, ZFP91P1 has been shown to promote cell migration and proliferation in pancreatic cancer cell lines. Knockdown of ZFP91P1 impairs proliferation and reverses markers of epithelial-mesenchymal transition (EMT), suggesting a role in cancer progression. It is not classified as a therapeutic target, drug receptor, enzyme, or classic signaling molecule[1]. The pseudogene may serve as a novel biomarker in pancreatic cancer but lacks evidence as a druggable target or as a functional protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZFP91 zinc finger protein pseudogene 1 (ZFP91P1).